Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 USD | +4.70% | +6.52% | -80.31% |
06-12 | Vivos Therapeutics, Inc. announced that it has received $7.5 million in funding | CI |
05-14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.31% | 7.91M | |
+75.69% | 12.57B | |
-25.26% | 7.29B | |
+14.20% | 7.11B | |
+15.12% | 5.5B | |
-17.48% | 4.83B | |
+16.16% | 4.14B | |
-23.67% | 3.78B | |
-29.30% | 2.67B | |
+2.35% | 2.09B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics Obtains FDA Approval for Device to Treat Sleep Apnea; Shares Surge Pre-Bell